IDEA Ideagen Plc

TIDMIDEA

RNS Number : 4627K

Ideagen PLC

02 September 2021

Ideagen PLC

("Ideagen," "the Company" or the "Group")

Total Voting Rights

In line with the Financial Conduct Authority's Disclosure and Transparency Rules, Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that as at today's date, the Company's total issued share capital is 254,655,400 ordinary shares of 1p each ("Ordinary Shares") and the total number of voting rights will therefore be 254,655,400.

There are no shares held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 
Ideagen plc                           01629 699 100 
Ben Dorks, Chief Executive Officer 
Emma Hayes, Chief Financial Officer 
 
finnCap Limited                       020 7220 0500 
Henrik Persson/James Thompson 
 (Nomad) 
Alice Lane (ECM) 
Canaccord Genuity                     020 7523 8000 
Simon Bridges 
Richard Andrews 
FTI Consulting                        020 3727 1000 
Jamie Ricketts                        ideagen@fticonsulting.com 
Dwight Burden 
Valerija Cymbal 
 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, over 6,000 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRLBMRTMTTMBMB

(END) Dow Jones Newswires

September 02, 2021 02:00 ET (06:00 GMT)

Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Ideagen (LSE:IDEA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024